Skip to main content
. 2004 Nov 10;7(1):R30–R37. doi: 10.1186/ar1453

Table 1.

Clinical characteristics of patients with juvenile rheumatoid arthritis

Parameter Systemic onset JRA (n = 20) Polyarticular JRA (n = 16) or pauciarticular JRA (n = 4)
Male/female 9/11 14/6
Mean age, years (range) 11.5 (2–23) 12.8 (3–22)
Mean disease duration, years (range) 4.1 (0.2–16) 5.8 (0.9–15)
No. with active arthritis (%) 17 (85) 17 (85)
No. with active systemic disease (%) 8 (40) -
Mean ESR, mm/h (range) 30 (5–85) 21 (5–57)
No. (%) receiving
 Prednisone 6 (30) 3 (15)
 Methotrexate 12 (60) 10 (50)
 TNF-blocking agent 3 (15) 5 (25)
 Intra-articular steroids 1 (5) 4 (20)
 NSAID 17 (85) 18 (90)

ESR, erythrocyte sedimentation rate; JRA, juvenile rheumatoid arthritis; NSAID, non-steroidal anti-inflammatory drugs; TNF, tumor necrosis factor.

HHS Vulnerability Disclosure